Stoneridge Investment Partners’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,041
| Closed | -$215K | – | 128 |
|
|
2020
Q3 | $215K | Buy |
+8,041
| New | +$215K | 0.14% | 101 |
|
|
2018
Q2 | – | Sell |
-56,176
| Closed | -$798K | – | 179 |
|
|
2018
Q1 | $798K | Sell |
56,176
-15,822
| -22% | -$225K | 0.13% | 90 |
|
|
2017
Q4 | $590K | Hold |
71,998
| – | – | 0.09% | 111 |
|
|
2017
Q3 | $853K | Sell |
71,998
-32,934
| -31% | -$390K | 0.13% | 111 |
|
|
2017
Q2 | $1.06M | Sell |
104,932
-158,798
| -60% | -$1.6M | 0.16% | 111 |
|
|
2017
Q1 | $3.07M | Sell |
263,730
-25,614
| -9% | -$298K | 0.41% | 87 |
|
|
2016
Q4 | $1.35M | Hold |
289,344
| – | – | 0.18% | 150 |
|
|
2016
Q3 | $2.24M | Sell |
289,344
-6,138
| -2% | -$47.5K | 0.32% | 111 |
|
|
2016
Q2 | $1.79M | Hold |
295,482
| – | – | 0.27% | 119 |
|
|
2016
Q1 | $2.52M | Sell |
295,482
-37,094
| -11% | -$316K | 0.37% | 93 |
|
|
2015
Q4 | $3.97M | Buy |
332,576
+77,179
| +30% | +$921K | 0.53% | 56 |
|
|
2015
Q3 | $2.57M | Sell |
255,397
-1,938
| -0.8% | -$19.5K | 0.36% | 86 |
|
|
2015
Q2 | $4.27M | Sell |
257,335
-51,409
| -17% | -$853K | 0.53% | 48 |
|
|
2015
Q1 | $4.78M | Buy |
308,744
+78,219
| +34% | +$1.21M | 0.56% | 51 |
|
|
2014
Q4 | $3.65M | Buy |
230,525
+163,327
| +243% | +$2.59M | 0.48% | 72 |
|
|
2014
Q3 | $717K | Sell |
67,198
-57
| -0.1% | -$608 | 0.11% | 169 |
|
|
2014
Q2 | $632K | Sell |
67,255
-2,050
| -3% | -$19.3K | 0.09% | 168 |
|
|
2014
Q1 | $478K | Sell |
69,305
-1,800
| -3% | -$12.4K | 0.09% | 125 |
|
|
2013
Q4 | $277K | Buy |
71,105
+38,963
| +121% | +$152K | 0.05% | 164 |
|
|
2013
Q3 | $162K | Buy |
+32,142
| New | +$162K | 0.04% | 195 |
|